Fundraising

Colossal Biosciences

Colossal Biosciences Raises $120M in Series

2021
Founded
100+
Employees
Austin, TX
2 min read

Quick Facts

Colossal Biosciences Raises $120M in Series


Colossal Biosciences has successfully raised $120M in a Series at a $800M valuation led by CIA In-Q-Tel, Breyer Capital.


Company Overview


Colossal Biosciences is a Biotech company headquartered in Austin, TX, founded in 2021 with 100+ employees.


Working on de-extinction of species including mammoths and dodos


Fundraising Details


  • Amount Raised: $120M
  • Round Type: Series
  • Valuation: $800M
  • Date: 2025-09-27
  • Investors: CIA In-Q-Tel, Breyer Capital

About Colossal Biosciences


Working on de-extinction of species including mammoths and dodos The company is positioned in the Biotech sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: Austin, TX
  • Founded: 2021
  • Team Size: 100+
  • Industry: Biotech

What This Means


This funding round demonstrates strong investor confidence in Colossal Biosciences's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. Colossal Biosciences's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $800M valuation marks an important milestone for Colossal Biosciences, positioning the company among notable players in the Biotech industry.


Looking Ahead


With this new capital, Colossal Biosciences is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2025-09-27. For more information about Colossal Biosciences, visit their headquarters at Austin, TX.

About the Author

Fundraising News Team
Fundraising News Team
Tracking the latest funding rounds and investment news